Stephen I. Katz

Q: What Schools Are Affiliated With Stephen I. Katz

Stephen I. Katz is affiliated with the following schools: University of Innsbruck, University of California, Berkeley, Louisiana State University, University of California, San Francisco, Uniformed Services University of the Health Sciences

Stephen I. Katz's AcademicInfluence.com Rankings

Stephen I. Katz

Medical

#372

World Rank

#524

Historical Rank

#157

USA Rank

Dermatology

#17

World Rank

#23

Historical Rank

USA Rank

medical Degrees

Stephen I. Katz

Biology

#3288

World Rank

#5046

Historical Rank

#1350

USA Rank

Immunology

#282

World Rank

#293

Historical Rank

#68

USA Rank

biology Degrees

Download Badge

Medical
Biology

Stephen I. Katz's Degrees

Masters Medicine University of California, San Francisco
Bachelors Chemistry University of California, Berkeley

Why Is Stephen I. Katz Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Stephen Ira Katz was an American immunodermatologist who served as the director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases from 1995 to 2018. He was the Marion B. Sulzberger Professor of Dermatology at the Uniformed Services University of the Health Sciences from 1989 to 1995.

(See a Problem?)

Stephen I. Katz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Epidermal Langerhans cells are derived from cells originating in bone marrow (1979) (915)
Immunologic functions of Ia-bearing epidermal Langerhans cells. (1978) (674)
Early molecular events in the induction phase of contact sensitivity. (1992) (669)
Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia (1981) (618)
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. (1993) (574)
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. (1980) (565)
An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. (1993) (436)
Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma (1992) (435)
Antibodies to type II collagen in relapsing polychondritis. (1978) (410)
Origin and Function of Epidermal Langerhans Cells (1980) (399)
Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. (2011) (392)
Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). (1981) (388)
Identification and induction of keratinocyte-derived IL-10. (1992) (347)
B-cell suppression of delayed hypersensitivity reactions (1974) (323)
Epidermal cell production of thymocyte activating factor (ETAF). (1982) (303)
Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. (1981) (262)
Epidermal cells adhere preferentially to type IV (basement membrane) collagen (1979) (246)
Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. (1988) (245)
Phenotypic and functional characteristics of in vivo-activated Langerhans cells. (1990) (244)
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. (1981) (243)
Localization of the collagenous component in skin basement membrane. (1978) (216)
Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. (1984) (210)
Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. (1997) (209)
Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. (1978) (205)
Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. (1982) (205)
Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. (1982) (202)
Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. (1981) (191)
Assessment of tissue fluid histamine levels in patients with urticaria. (1978) (186)
Ia antigens in mouse skin are predominantly expressed on Langerhans cells. (1979) (184)
Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. (1995) (184)
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. (1984) (183)
Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation. (1985) (182)
Autoimmune vitiligo: detection of antibodies to melanin-producing cells. (1977) (181)
ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE (1977) (180)
Herpes gestationis. Immunopathology and characterization of the HG factor. (1976) (174)
Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. (1984) (168)
Detection of Ia antigens on Langerhans cells in guinea pig skin. (1978) (165)
Dermatitis herpetiformis: the skin and the gut. (1980) (157)
Structure and function of basement membrane. (1982) (147)
Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen. (1987) (147)
The pathogenesis of dermatitis herpetiformis. (1978) (146)
Detection of basement membrane zone antigens during epidermal wound healing in pigs. (1981) (145)
Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits. (1980) (142)
Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. (1988) (139)
Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation. (1986) (137)
Detection of specific collagen types in normal and keratoconus corneas. (1981) (137)
Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. (1996) (136)
Dermatologic changes associated with interleukin 2 administration. (1987) (135)
Fitzpatrick's Dermatology in General Medicine. 7th Edition (2008) (131)
HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy. (1972) (127)
Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. (1998) (124)
Fetal and maternal risk factors in herpes gestationis. (1978) (123)
Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells (1994) (120)
Immunoelectronmicroscopic localization of IgA in skin of patients with dermatitis herpetiformis. (1976) (113)
The epidermal basement membrane zone--structure, ontogeny, and role in disease. (1984) (112)
IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases. (1980) (111)
The functional role of Langerhans cells. (1980) (107)
Pruritic urticarial papules and plaques of pregnancy. (1979) (106)
Demonstration of circulating immune complexes in Sjögren's syndrome. (1979) (103)
Expression of basement membrane zone antigens at the dermo-epibolic junction in organ cultures of human skin. (1980) (98)
Induction of tolerance to topically applied TNCB using TNP-conjugated ultraviolet light-irradiated epidermal cells. (1981) (98)
The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes. (1988) (97)
Laminin and bullous pemphigoid antigen are distinct basement membrane proteins synthesized by epidermal cells. (1982) (96)
Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease. (1983) (91)
Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. (1995) (89)
SPECIFIC B-CELL ANTIGENS ASSOCIATED WITH GLUTEN-SENSITIVE ENTEROPATHY AND DERMATITIS HERPETIFORMIS (1976) (89)
The epidermal cell which selectively adheres to a collagen substrate is the basal cell. (1980) (87)
Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. (1998) (87)
Antigen presentation and T-cell activation in epidermodysplasia verruciformis. (1990) (86)
The role of Langerhans cells in antigen presentation. (1985) (85)
Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. (1997) (84)
Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. (1988) (84)
The role of epidermal cells in the induction and suppression of contact sensitivity. (1981) (84)
KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa. (1984) (83)
Characterization of epitopes recognized by hapten-specific CD4+ T cells. (1995) (83)
The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. (1988) (82)
Collagen, factor VIII antigen, and immunoglobulins in the human aqueous drainage channels. (1980) (81)
Induction of skewed Th1/Th2 T‐cell differentiation via subcutaneous immunization with Freund's adjuvant (2002) (81)
A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors (1982) (79)
Human Langerhans cells express E-cadherin. (1995) (79)
Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. (2004) (79)
Herpes gestationis. Ultrastructure and ultrastructural localization of in vivo-bound complement. (1976) (78)
Suppressor cells in normal immunisation as a basic homeostatic phenomenon (1974) (75)
Early events in the induction phase of contact sensitivity. (1992) (72)
The skin as an immunologic organ. (1985) (72)
T helper cells grown with hapten‐modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells (1989) (72)
Immunofluorescent detection of human B cell alloantigens on S-Ig-positive lymphocytes and epidermal Langerhans cells. (1978) (69)
Immunization through dermal delivery of protein‐encoding DNA: a role for migratory dendritic cells (1999) (69)
Retinoic acid delays the terminal differentiation of keratinocytes in suspension culture. (1981) (67)
The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. (1991) (67)
Circulating IgA anti-basement membrane zone antibodies in dermatitis herpetiformis. (1977) (66)
Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. (2003) (66)
Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. (2009) (65)
Contact sensitivity as a model for T-cell activation in skin. (1995) (65)
Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). (1983) (65)
Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. (1998) (65)
The origin of Langerhans cells. (1980) (64)
The use of mouse models to better understand mechanisms of autoimmunity and tolerance. (2010) (64)
Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. (1986) (61)
The appearance of four basement membrane zone antigens in developing human fetal skin. (1984) (60)
Thy-1+ dendritic cells in murine epidermis are bone marrow-derived. (1984) (60)
Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. (2002) (60)
HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. (1973) (60)
Bullous eruption of systemic lupus erythematosus. (1982) (59)
Reversal of CD8 T-Cell–Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib (2013) (56)
Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. (1991) (56)
Direct effects of glucocorticosteroids on epidermal Langerhans cells. (1989) (56)
Necrolytic migratory erythema without glucagonoma. (1979) (56)
Fluorescence microscopic and flow cytometric analysis of bone marrow-derived cells in human epidermis: a search for the human analogue of the murine dendritic Thy-1+ epidermal cell. (1985) (55)
Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific anti-epithelial cell antibody. (1978) (54)
Characterization of a porcine CD1-specific mAb that distinguishes CD4/CD8 double-positive thymic from peripheral T lymphocytes. (1990) (54)
Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes. (1986) (53)
Necrolytic Migratory Erythema Without Glucagonoma: Report of Two Cases (1979) (53)
Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells. (1994) (53)
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells (2012) (53)
A unique epithelial basement membrane antigen defined by a monoclonal antibody (KF-1). (1983) (53)
Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes. (2014) (53)
Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation. (2015) (52)
The Use of Human Skin for the Detection of Antiepithelial Autoantibodies (1969) (52)
Detection of pemphigoid antigen, pemphigus antigen, and keratin filaments by indirect immunofluorescence in cultured human epidermal cells. (1980) (51)
Human Herpesvirus 6 Infects Dendritic Cells and Suppresses Human Immunodeficiency Virus Type 1 Replication in Coinfected Cultures (1999) (50)
Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis. (1989) (50)
Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions. (1976) (49)
Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. (1990) (48)
UVB Induces IL‐12 Transcription in Human Keratinocytes in vivo and in vitro (1996) (47)
Antigen presentation and allogeneic stimulation by Langerhans cells. (1980) (45)
Cell-mediated immunity in cutaneous disease. (1986) (44)
Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells (2001) (44)
Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. (1993) (43)
Dermatitis herpetiformis: immunoelectronmicroscopic and ultrastructural studies of a patient with linear deposition of IgA. (1976) (43)
Generation of mature dendritic cells from a CD14+ cell line (XS52) by IL-4, TNF-alpha, IL-1 beta, and agonistic anti-CD40 monoclonal antibody. (1999) (43)
Ontogeny of Langerhans cells. (1980) (42)
HLA-B8 and dermatitis herpetiformis in patients with IgA deposits in skin. (1977) (42)
Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12. (1996) (40)
Remission in dermatitis herpetiformis: a cohort study. (2011) (38)
Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. (1986) (34)
HL-A antigens in pemphigus. (1973) (34)
Immunofluorescence labelling of gonadotropin receptors in enzyme-dispersed interstitial cells (1976) (33)
Herpes Gestationis: A Clinicopathologic Study (1976) (30)
Generation and Characterization of T‐helper Cells by Primary in vitro Sensitization using Langerhans Cells (1990) (30)
Basophilic leukocytes in delayed hypersensitivity reactions. (1974) (30)
Nidogen and heparan sulfate proteoglycan: detection of newly isolated basement membrane components in normal and epidermolysis bullosa skin. (1987) (29)
Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells. (1989) (28)
Dermatitis herpetiformis. Immunologic concomitants of small intestinal disease and relationship to histocompatibility antigen HL-A8. (1974) (28)
Culture and characterization of murine dendritic Thy-1+ epidermal cells. (1986) (28)
Relative effectiveness of selected sunscreens. (1970) (28)
CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease. (2014) (28)
Recruitment of basophils in delayed hypersensitivity reactions. (1978) (27)
Cultured human Langerhans cells process and present intact protein antigens. (1992) (25)
Collared mice: a model to assess the effects of scratching. (2010) (25)
BONE MARROW TRANSPLANTATION IN MINIATURE SWINE: III. GRAFT‐VERSUS‐HOST DISEASE AND THE EFFECT OF T CELL DEPLETION OF MARROW (1988) (25)
Basic science: Bedrock of progress. (2016) (25)
Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects. (1995) (24)
IL-15 Serves as a Costimulator in Determining the Activity of Autoreactive CD8 T Cells in an Experimental Mouse Model of Graft-versus-Host-Like Disease1 (2008) (24)
Production of macrophage inhibitory factor by patients with leprosy. (1971) (23)
Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. (1981) (23)
Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation. (1988) (23)
IMMUNOPATHOLOGY AND CHARACTERIZATION OF THE HG FACTOR (1976) (23)
Thy-1-positive dendritic epidermal cells contain a killer protein perforin. (1990) (23)
Specific immunologic tolerance to dinitrofluorobenzene following topical application of dinitrothiocyanobenzene: modulation by suppressor T cells. (1983) (23)
Immunopathology of cutaneous graft-versus-host disease. (1987) (22)
Sebaceous gland papules in anhidrotic ectodermal dysplasia. (1971) (22)
Immune modulation by epidermal cell products: possible role of ETAF in inflammatory and neoplastic skin diseases. (1982) (21)
The skin as target, vector, and effector organ in human immunodeficiency virus disease. (1995) (21)
Contact Hypersensitivity (2001) (19)
Psychiatric reaction to dapsone and sulfapyridine. (1983) (19)
IgA-containing circulating immune complexes in gluten-sensitive enteropathy. (1981) (18)
Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine. (1990) (18)
In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. (1986) (18)
Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF). (1985) (18)
The role of Langerhans' cells in immunity. (1980) (17)
Expression of Ia antigen by ocular tissues of mice treated with interferon gamma. (1989) (17)
Strain variation in the induction of tolerance by epicutaneous application of trinitrochlorobenzene. (1983) (16)
Epidermal Langerhans cells can function as stimulatory cells but not as accessory cells in CTL induction. (1984) (16)
Serum complement (C'3) levels in patients with autoimmune bullous skin diseases. (1970) (16)
Differential inhibition of the T cell activation pathway by dexamethasone and cyclosporine. (1990) (15)
Identification of CD3+CD4-CD8-T cells as potential regulatory cells in an experimental murine model of graft vs. host skin disease (GvHD) (2013) (15)
Viral studies in pemphigus. (1974) (14)
The Skin as an Immunological Organ: Allergic Contact Dermatitis as a Paradigm (1993) (13)
Blistering skin diseases: new insights. (1985) (13)
TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells. (1985) (12)
Characterization of primary T helper cell activation and T helper cell lines stimulated by hapten-modified, cultured Langerhans cells. (1989) (12)
AOA Symposium. Barriers (threats) to clinical research. (2008) (12)
Pemphigus and herpes simplex. Antibody response to corticosteroids in a patient. (1970) (12)
Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells. (2006) (12)
The use of human skin for the detection of anti-epithelial autoantibodies. A diagnostic and prognostic test. (1969) (11)
Dermatitis herpetiformis flare associated with use of triiodomethane packing strips for alveolar osteitis. (2009) (11)
Self-Peptides Prolong Survival in Murine Autoimmunity via Reduced IL-2/IL-7-Mediated STAT5 Signaling, CD8 Coreceptor, and Vα2 Down-Regulation1 (2009) (10)
Mechanisms involved in the expression of Jones-Mote hypersensitivity. II. Lymph node morphology and in vitro correlates. (1975) (10)
Monoclonal antibodies in dermatologic research. Studies with a unique cell-surface antigen defined specifically for keratinocytes by a monoclonal antibody. (1985) (10)
Quantitative differences in cell surface expression of class I MHC antigens on murine epidermal Langerhans cells. (1994) (9)
The epidermal basement membrane: structure, ontogeny and role in disease. (2008) (9)
Immunofluorescent localization of basement membrane in lesions of dermatitis herpetiformis. (1976) (9)
IMMUNOPATHOLOGICAL AND CLINICAL STUDIES IN HERPES GESTATIONIS (1981) (9)
"Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis. (1982) (9)
Mechanisms involved in the expression of Jones-Mote hypersensitivity. I. Passive cell transfer studies. (1975) (9)
Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells. (1988) (9)
The Transfer of Laboratory Training (1976) (9)
Mechanisms involved in allergic contact dermatitis. (1990) (9)
Subtle clues to diagnosis by immunopathology. Relapsing polychondritis. (1979) (8)
Freshly isolated Thy-1+ dendritic epidermal cells express T cell receptor γδ-CD3 (1990) (7)
Inherited and acquired blistering diseases. (1992) (7)
Murine epidermal Langerhans Cells Do Not Express the Low-Affinity Receptor for Immunoglobulin E, FcεRII (CD23) (1996) (7)
Modulation of antigen presenting cell function by in vivo administration of anti ia antibodies (1985) (6)
Microscopic approach to true leukonychia (1993) (6)
Contact Hypersensitivity (1993) (6)
Generation of Mature Dendritic Cells from a CD14+ Cell Line (XS52) by IL-4, TNF-α, IL-1β, and Agonistic Anti-CD40 Monoclonal Antibody (1999) (6)
Development and characterization of trinitrophenyl-specific L3T4+ T-cell clones. (1986) (6)
The current status of investigative dermatology (1983) (6)
The muscular dystrophy coordinating committee action plan for the muscular dystrophies (2016) (5)
Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. (2002) (5)
Herpes gestationis. A clinicopathologic study. (1977) (5)
Extraction and quantitation of cytokine mRNA from human epidermal blister roofs (2004) (5)
Suppressor cells in delayed hypersensitivity reactions. (1974) (4)
Demonstration of suppressor cells in delayed hypersensitivity by B lymphocytes. (1975) (4)
Boning Up for Health: The National Bone and Joint Decade (2004) (4)
Human CD8+ xenoreactive T cells mediate tissue injury in vivo. (1993) (4)
Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity. (2012) (4)
Murine epidermal Langerhans cells do not express the low-affinity receptor for immunoglobulin E, FcEpsilonRII (CD23). (1996) (4)
Dermatological allergy (1973) (4)
The Relationship of the Mid-Life Transition to Death Anxiety and Self Actualization. (1978) (4)
Immunopathology of the Skin (2nd ed.). (1981) (3)
The current status of investigative dermatology II (2010) (3)
Histocompatibility antigens and disease. (1977) (3)
The role of Langerhans cells in allergic contact dermatitis. (1986) (3)
EPIDERMAL CELLS ADHERE PREFERENTIALLY TO TYPE IV (1979) (3)
LANGERHANS CELL - LYMPHOCYTE INTERACTIONS (1980) (3)
Immunological aspects of acute cutaneous graft-versus-host disease (1983) (3)
Dermatological research in the new millennium. (2001) (3)
Barriers (Threats) to Clinical Research (2008) (3)
Proceedings of the 34th Annual Symposium on the Biology of Skin Cutaneous Immunobiology (1985) (2)
The national bone and joint decade: impact for rheumatic diseases. (2005) (2)
Response to: "Rescuing the NIH before it is too late". (2006) (2)
Eczematous and immunologic diseases. (1984) (2)
Herpes gestationis. An update. (1977) (2)
Early events in contact sensitivity. (1995) (2)
Induction of Cell‐Mediated Cytotoxic Self Responses by Epidermal Cells Modified with a Haptenic Sulphydryl Reagent (1982) (2)
Effects of in vivo administration of anti-Ia antibodies on contact sensitivity. (1989) (2)
The skin as an immunologic organ A tribute to Marion B. Sulzberger. (1985) (2)
Juvenile dermatitis herpetiformis: an immunologically proven case. (1977) (2)
Commentary: Setting priorities for research funding at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). (2015) (2)
Workshop on immune mechanisms in cutaneous disorders. (1980) (1)
Irwin Freedberg and the government. (2006) (1)
Perspectives and speculations. (1983) (1)
Molecules on activated human T-cells. (1988) (1)
Thematic Review Series VI: Skin Gene Therapy (1999) (1)
NIH centennial: the influence of NIH on dermatology research training. (1989) (1)
Ultraviolet B exposure induces interleukin-10 expression in human keratinocytes (1993) (1)
Musculoskeletal research at the National Institute of Arthritis and Musculoskeletal and Skin Diseases: a snapshot. (2009) (1)
Freshly isolated Thy-1+ dendritic epidermal cells express T cell receptor gamma delta-CD3. (1990) (1)
Mr. Kozak's regime for epidermolysis bullosa (1983) (1)
Dermatological Research in the 21st Century: Our Fantastic Future (2001) (1)
The skin as an immunologic organ. A tribute to Marion B. Sulzberger. (1985) (1)
Br AND Wh, B CELL ANTIGENS IN GLUTEN SENSITIVE ENTEROPATHY AND DERMATITIS HERPETIFORMIS (1976) (1)
Pemphigus-like antibodies in sera of patients with thermal burns, gunshot wounds, and skin grafts. (1974) (1)
Wolfram Sterry: Physician – Scientist – Cosmopolitan (2014) (1)
Remission in Dermatitis Herpetiformis (2017) (1)
Human herpesvirus 6 (HHV6) infects dendritic cells (DC) and suppresses HIV replication in co-infected cultures (1998) (1)
Celiac-sprue and the gluten free diet (1982) (0)
The society for investigative dermatology: Essential for the future of our specialty (1983) (0)
The society for investigative dermatology: Essential for the future of our specialty (1983) (0)
411 KERATINOCYTES INDUCE GRAFT-VERSUS-HOST DISEASE BY PRESENTATION OF EPIDERMAL SELF-ANTIGEN TO CD8 T CELLS. (2007) (0)
Malignant and Non-Malignant Diseases in Relatives of Patients with Dermatitis Herpetiformis and Coeliac Disease: A Preliminary Report (1981) (0)
Endocrine, metabolic and immunologic functions of keratinocytes, Leonard M. Milstone, Richard L. Edelson (Eds.). New York Academy of Sciences, New York (1988), 366, $92.00 (1990) (0)
Gluten-Free Diet in Patients With Dermatitis Herpetiformis: Not Only a Matter of Skin —Reply (2011) (0)
Common goals and challenges in dermatological research in Eastern Europe. (2010) (0)
Herpes Gestationis-Reply (1977) (0)
Pemphigus as an autoaggressive phenomenon. (1971) (0)
[Current status of dermatology research]. (1984) (0)
Pioneers in Dermatology and Venereology: an interview with Stephen I. Katz, MD, PhD (2018) (0)
Dermatitis Herpetiformis, Volume IV of Major Problems in Dermatology (Book) (1976) (0)
PD-1 regulates autoimmune CD8 T cell-mediated mucocutaneous disease of ‘interface dermatitis’ via PD-L1 expressed on target epidermal cells (2016) (0)
13.Thy-1陽性樹枝状表皮細胞におけるT細胞レセプターの表現 (1988) (0)
Induction of mature dendritic cells from a murine epidermal dendritic cell line (XS52) using interleukin-4 (1998) (0)
Discontinuing Dapsone Treatment and Reintroducing Dietary Gluten in Patients With Dermatitis Herpetiformis in Remission (2017) (0)
Unity in action. (2014) (0)
Stefania Jabłońska (1920–2017) (2018) (0)
Functional Capacities of Ia-Bearing Langerhans Cells (1978) (0)
Effective prevention and treatment of CD8 T cell-mediated graft-versus-host-like disease (GvHD) using a JAK inhibitor. (51.3) (2012) (0)
Suction Blister Apparatus (1983) (0)
lymphoid independence of dendritic cells knockout donor cells demonstrates the α Use of interleukin 7 receptor (2013) (0)
Harvey Blank, 1918–2001 (2003) (0)
Biochemical and functional characteristics of class II MHC antigen (Ia) on freshly-prepared Langerhans cells (fLC) and cultured Langerhans cells (cLC) (1991) (0)
Subtle clues to diagnosis by immunopathology. Leukocytoclastic vasculitis. (1979) (0)
Harvey Blank, 1918-2001 (2003) (0)
Elimination of epidermal Langerhans cells or impairment of dermal dendritic cells does not abrogate the induction of localized graft-versus-host-disease-like skin disease (2006) (0)
The Year Book of Dermatology 1977 (Book) (1978) (0)
Characterization of class II MHC molecules on kera tinocytes (1990) (0)
Thematic Review Series VI: Skin Gene Therapy Introduction. (1999) (0)
PL005 Advances in the immunobiology of the skin (1997) (0)
Coping with Death in the Family (1981) (0)
Recent developments in clinical research. vol. 13 of current problems in dermatology: C. E. Orfanos, M.D., editor, Basel, 1985, S. Karger AG. 192 pages, $98.25. (1985) (0)
Clinical Dermatology Update International Meeting of the International League of Dermatological Societies Florence, March 4–7, 7999 (1999) (0)
The Role of Interleukin-1β and Interleukin-10 in Langerhans Cell-Mediated Immune Responses (1995) (0)
Hapten specific tri nitro phenyl reactive cyto toxic effector cells using epidermal cells as targets (1981) (0)
2 Down-Regulation a Coreceptor, and V IL-2/IL-7-Mediated STAT5 Signaling, CD8 Autoimmunity via Reduced Self-Peptides Prolong Survival in Murine (2009) (0)
Training at the NIAMS: ensuring a vibrant future for musculoskeletal research. (2009) (0)
Graft-versus-Host-Like Disease T Cells in an Experimental Mouse Model of CD 8 Determining the Activity of Autoreactive IL-15 Serves as a Costimulator in Waldmann and (2008) (0)
Twists and Turns on the Road to Becoming a Physician-Scientist (2011) (0)
Langerhans cell-containing epidermal cells are not cytotoxic in antibody-dependent- and mitogen-induced-cellular cytotoxicity. (1982) (0)
Mouse models of skin autoimmunity and peripheral tolerance (2004) (0)
SID 2015 Contributors. (2015) (0)
Dermatitis herpetiformis (2005) (0)
Prospects for targeted gene therapy (2000) (0)
18th World Congress of Dermatology. (1992) (0)
A role for keratinocyte-derived IL-10 in the induction of tolerance in cutaneous immune responses (1993) (0)
Graft Versus Host Disease (GVHD) (2016) (0)

This paper list is powered by the following services:

Other Resources About Stephen I. Katz

en.wikipedia.org

What Schools Are Affiliated With Stephen I. Katz?

Stephen I. Katz is affiliated with the following schools:

Stephen I. Katz's Academic­Influence.com Rankings

Stephen I. Katz's Degrees

Why Is Stephen I. Katz Influential?

Stephen I. Katz's Published Works

Published Works

Other Resources About Stephen I. Katz

What Schools Are Affiliated With Stephen I. Katz?

Stephen I. Katz's AcademicInfluence.com Rankings